BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 35411083)

  • 41. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
    Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
    Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity.
    Beerling E; Seinstra D; de Wit E; Kester L; van der Velden D; Maynard C; Schäfer R; van Diest P; Voest E; van Oudenaarden A; Vrisekoop N; van Rheenen J
    Cell Rep; 2016 Mar; 14(10):2281-8. PubMed ID: 26947068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors.
    Malik S; Villanova L; Tanaka S; Aonuma M; Roy N; Berber E; Pollack JR; Michishita-Kioi E; Chua KF
    Sci Rep; 2015 Apr; 5():9841. PubMed ID: 25923013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states.
    Toneff MJ; Sreekumar A; Tinnirello A; Hollander PD; Habib S; Li S; Ellis MJ; Xin L; Mani SA; Rosen JM
    BMC Biol; 2016 Jun; 14():47. PubMed ID: 27317311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Notch-1-mediated esophageal carcinoma EC-9706 cell invasion and metastasis by inducing epithelial-mesenchymal transition through Snail.
    Wang T; Xuan X; Pian L; Gao P; Hu H; Zheng Y; Zang W; Zhao G
    Tumour Biol; 2014 Feb; 35(2):1193-201. PubMed ID: 24022665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis.
    Zhang H; Meng F; Liu G; Zhang B; Zhu J; Wu F; Ethier SP; Miller F; Wu G
    Cancer Res; 2011 Feb; 71(4):1292-301. PubMed ID: 21285253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epithelial-to-mesenchymal transition in tumor progression.
    Prieto-García E; Díaz-García CV; García-Ruiz I; Agulló-Ortuño MT
    Med Oncol; 2017 Jul; 34(7):122. PubMed ID: 28560682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.
    Thomas C; Rajapaksa G; Nikolos F; Hao R; Katchy A; McCollum CW; Bondesson M; Quinlan P; Thompson A; Krishnamurthy S; Esteva FJ; Gustafsson JÅ
    Breast Cancer Res; 2012 Nov; 14(6):R148. PubMed ID: 23158001
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.
    Chang CW; Yu JC; Hsieh YH; Yao CC; Chao JI; Chen PM; Hsieh HY; Hsiung CN; Chu HW; Shen CY; Cheng CW
    Oncotarget; 2016 Mar; 7(13):16462-78. PubMed ID: 26918943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities.
    Zhang Y; Weinberg RA
    Front Med; 2018 Aug; 12(4):361-373. PubMed ID: 30043221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
    Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
    Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EMT and MET: necessary or permissive for metastasis?
    Jolly MK; Ware KE; Gilja S; Somarelli JA; Levine H
    Mol Oncol; 2017 Jul; 11(7):755-769. PubMed ID: 28548345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.
    McCart Reed AE; Kutasovic JR; Vargas AC; Jayanthan J; Al-Murrani A; Reid LE; Chambers R; Da Silva L; Melville L; Evans E; Porter A; Papadimos D; Thompson EW; Lakhani SR; Simpson PT
    J Pathol; 2016 Mar; 238(4):489-94. PubMed ID: 26510554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transition.
    Malouf GG; Taube JH; Lu Y; Roysarkar T; Panjarian S; Estecio MR; Jelinek J; Yamazaki J; Raynal NJ; Long H; Tahara T; Tinnirello A; Ramachandran P; Zhang XY; Liang S; Mani SA; Issa JP
    Genome Biol; 2013 Dec; 14(12):R144. PubMed ID: 24367927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A double-negative feedback loop between DEAD-box protein DDX21 and Snail regulates epithelial-mesenchymal transition and metastasis in breast cancer.
    Zhang H; Zhang Y; Chen C; Zhu X; Zhang C; Xia Y; Zhao Y; Andrisani OM; Kong L
    Cancer Lett; 2018 Nov; 437():67-78. PubMed ID: 30165191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epithelial-mesenchymal plasticity: emerging parallels between tissue morphogenesis and cancer metastasis.
    Plygawko AT; Kan S; Campbell K
    Philos Trans R Soc Lond B Biol Sci; 2020 Oct; 375(1809):20200087. PubMed ID: 32829692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.
    Ruscetti M; Dadashian EL; Guo W; Quach B; Mulholland DJ; Park JW; Tran LM; Kobayashi N; Bianchi-Frias D; Xing Y; Nelson PS; Wu H
    Oncogene; 2016 Jul; 35(29):3781-95. PubMed ID: 26640144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EMT, cell plasticity and metastasis.
    Chaffer CL; San Juan BP; Lim E; Weinberg RA
    Cancer Metastasis Rev; 2016 Dec; 35(4):645-654. PubMed ID: 27878502
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SURVIVIN as a marker for quiescent-breast cancer stem cells-An intermediate, adherent, pre-requisite phase of breast cancer metastasis.
    Siddharth S; Das S; Nayak A; Kundu CN
    Clin Exp Metastasis; 2016 Oct; 33(7):661-75. PubMed ID: 27411340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
    Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
    BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.